z-logo
open-access-imgOpen Access
Dynamics of the microbiological scope and antibiotic susceptibility in intensive care unit patients
Author(s) -
Kostiv Olga,
Yakymchuk Elena,
S. Ya. Kostiv,
Dmytro Dmytrіiev,
Kostiantyn Dmytriiev
Publication year - 2020
Publication title -
biomedical research and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 1
ISSN - 2198-4093
DOI - 10.15419/bmrat.v7i7.615
Subject(s) - medicine , imipenem , antibiotics , pseudomonas aeruginosa , antibiotic resistance , intensive care unit , klebsiella pneumoniae , intensive care medicine , infection control , microbiology and biotechnology , bacteria , biology , biochemistry , genetics , escherichia coli , gene
This study addresses and evaluates the decrease of antibiotic resistance after introduction of a proposed prevention plan and control complex in the intensive care unit (ICU). Methods: Data from 1,111 bacteriological analyses, taken from patients who received treatment in the ICU of Ternopil University Hospital from January to August 2015 (group 1) and the same period of 2018 (group II), were included in the study. The complex included measures for the prevention of antibiotic resistance spread and for rational antibiotic use. Results: We found that resistance to imipenem changed more than other antibacterial drugs, increased by 60% (р ≤ 0.05), which was conditioned predominantly by Pseudomonas aeruginosa isolates for 100%. A decrease in 39% of polyresistant clinical isolates of Klebsiella pneumoniae in patients of groups I and II showed important prognostic value. Conclusion: A complex of the proposed measures included the division of patients in blocks according to the risk of infectious complications, control of antibiotics administration, adherence to sanitary norms by ICU staff, use of sodium hypochlorite resulting in decrease of pathogenic isolates, and level of antibiotic resistance to specific groups of antibacterial drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here